Life Science Fundraising & Investment
24 March 2026 - Pre-day forums (Life Science Companies only), FIL (Feira Internacional de Lisboa)25-26 March 2026 - Main days, Lisbon Congress Centre, Lisbon, Portugal Jeremy SkillingtonCEO at Poolbeg PharmaSpeaker
Profile
Jeremy Skillington has a PhD in Biochemistry and spent 7 years at Genentech he executed over 40 licencing and other transactions. He has since been involved in a number of successful biotech start ups including inflazome which was acquired by Roche in a deal worth over USD410 million
Agenda Sessions
Unlocking Opportunities in Public Markets: Strategies for Biotech Success
, 11:10View Session